0001654954-18-002717.txt : 20180316
0001654954-18-002717.hdr.sgml : 20180316
20180316171420
ACCESSION NUMBER: 0001654954-18-002717
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171116
FILED AS OF DATE: 20180316
DATE AS OF CHANGE: 20180316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cross Shawn
CENTRAL INDEX KEY: 0001734779
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-08092
FILM NUMBER: 18696606
MAIL ADDRESS:
STREET 1: 1825 K STREET SUITE 510
CITY: WASHINGTON
STATE: DC
ZIP: 20006
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GT Biopharma, Inc.
CENTRAL INDEX KEY: 0000109657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 941620407
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1825 K STREET
STREET 2: SUITE 510
CITY: WASHINGTON, D.C.
STATE: DC
ZIP: 33602
BUSINESS PHONE: (800) 304-9888
MAIL ADDRESS:
STREET 1: 1825 K STREET
STREET 2: SUITE 510
CITY: WASHINGTON, D.C.
STATE: DC
ZIP: 33602
FORMER COMPANY:
FORMER CONFORMED NAME: OXIS INTERNATIONAL INC
DATE OF NAME CHANGE: 19940916
FORMER COMPANY:
FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/
DATE OF NAME CHANGE: 19850312
3
1
section16.xml
PRIMARY DOCUMENT
X0206
3
2017-11-16
1
0000109657
GT Biopharma, Inc.
GTBP
0001734779
Cross Shawn
1825 K STREET SUITE 510
WASHINGTON
DC
20006
true
true
false
false
Chief Executive Officer
/s/Shawn Cross
2018-03-16